Athira Pharma, Inc. (ATHA) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -20.9M | -19.4M | -4.67M | -7M | -14.66M | -26.01M | -23.02M | -22.33M | -25.8M | -26.29M | -23.98M | -24.28M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -42.54% | 25.43% | 79.72% | 68.66% | 43.17% | 1.06% | 4.01% | 8.04% | 1.49% | -67.82% | -10.83% | -30.62% |
| Net Income | -32.95M | -82.89M | -6.61M | -6.97M | -9.14M | -15M | -28.74M | -26.86M | -26.34M | -27.29M | -32.97M | -29.6M |
| Depreciation & Amortization | -29K | 241K | 243K | 116K | 243K | 243K | -245K | 242K | 242K | 245K | 244K | 244K |
| Stock-Based Compensation | 662K | 1.46M | 1.41M | 1.6M | 1.64M | 2.23M | 2.94M | 3.21M | 2.68M | 2.23M | 2.49M | 3.12M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.14M | -394K | 0 |
| Other Non-Cash Items | 11.41M | 71.01M | -1K | 67K | 0 | 36K | 493K | -106K | -202K | 3.91M | 54K | -353K |
| Working Capital Changes | 0 | -9.21M | 291K | -1.81M | -7.4M | -13.52M | 2.53M | 1.19M | -2.19M | -1.25M | 6.59M | 2.31M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 1.63M | 0 | 0 | 0 | -1.63M | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -3.36M | -10.96M | -207K | -2.52M | -7.66M | -4.63M | 838K | 1.29M | -3.25M | 208K | 6.95M | 0 |
| Cash from Investing | -15.54M | -14.64M | 5.65M | 441K | -7.35M | -2.81M | 18.04M | 26.56M | 13.04M | 6.39M | 20.69M | 32.49M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -28K | -5K | 0 | -30K | -33K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -20.72K | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20.72K | 0 |
| Cash from Financing | 0 | 82.44M | 0 | 24K | 0 | 34K | 12K | 148K | 0 | 152K | 0 | 242K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | 0 | 24K | 0 | 34K | 12K | 148K | 0 | 152K | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | -24K | 0 | 24K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 82.44M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 242K |
| Net Change in Cash | -36.44M | 48.4M | 986K | -6.53M | -22.02M | -28.79M | -4.97M | 4.38M | -12.76M | -19.75M | -3.29M | 8.45M |
| Free Cash Flow | -20.9M | -19.4M | -4.67M | -7M | -14.66M | -26.01M | -23.02M | -22.36M | -25.81M | -26.29M | -24.01M | -24.32M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -42.54% | 25.43% | 79.72% | 68.7% | 43.18% | 1.06% | 4.13% | 8.05% | 2.37% | -67.81% | -9.73% | -29.74% |
| FCF per Share | -1.10 | -4.54 | -1.18 | -1.79 | -3.76 | -6.76 | -5.98 | -5.83 | -6.73 | -6.90 | -6.31 | -6.40 |
| FCF Conversion (FCF/Net Income) | 0.63x | 0.23x | 0.71x | 1.00x | 1.60x | 1.73x | 0.80x | 0.83x | 0.98x | 0.96x | 0.73x | 0.82x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |